Please click
 User   Pwd      Remember
Article Search: 
BiotechEast
· Home
· About us
· Services
· FAQ
· Contact us
Info Resources
· Companies
· Institutes
· Science parks
· Life science news
· Company spotlight
· Taiwan bio report
· Feature articles
· Asia-Pacific events
· Investment corner
· Technology transfer
· Int'l biotech links
· Info resources search
· Job listings
· Log out
Partners
1 2 3 4 5 6 7 8 9 10 ... Total pages:253  Next 

Life Science News

(Taiwan) Taiwanese funds invest in genetic medicine initiative


(WantChinaTimes.com)

15 February, 2015
Taiwan's venture capital companies are eyeing investing in genetic testing to diagnose diseases, reports our Chinese-language sister paper Commercial Times.
More...




Life Science News

(Taiwan) ASLAN Pharmaceuticals appoints Dr Bertil Lindmark as Chief Scientific Officer


(BiotechEast staff)

28 January, 2015
ASLAN Pharmaceuticals Pte Ltd, an oncology-focused biotechnology company, announced last week the appointment of Dr Bertil Lindmark as Chief Scientific Officer.




Life Science News

(Taiwan) GNT receives EU food additive certification for its gold flake product


(BiotechEast staff)

29 January, 2015
Taipei, Taiwan-headquartered biotech-nanotech product development company Gold Nanotech Inc. (GNT) announced this week that it had received notification of compliance to the European Union's food additive regulation E175 for its edible gold flake product




Life Science News

(Taiwan) Chang Gung bone bank helps save medical expenses: physician


(Focus Taiwan)

21 December, 2014
Chang Gung Memorial Hospital is proud of its achievements in running a bone bank, including helping save Taiwan NT$6 billion (US$190 million) in medical expenditures since it was set up in 1984.
More...




Life Science News

(Taiwan) Cancer communication cracked


(Taipei Times)

15 December, 2014
National Yang-Ming University and Taipei Veterans General Hospital recently unveiled a breakthrough finding that explains how cancer cells promote the recruitment of tumor-associated macrophages to remodel a tumorís microenvironment to aid growth.
More...




Life Science News

(Taiwan) Price of MedeonBio stock triples after market debut


(Taipei Times)

15 December, 2014
Shares of Medeon Biodesign Inc (益安生醫), which makes medical devices for minimally invasive surgeries, tripled in value from Tuesday through Friday after its debut on the Emerging Stock Market, as investors have high hopes for its management team.
More...




Life Science News

(Taiwan) Taiwan and the Fight Against Ebola


(The Diplomat)

9 December, 2014
Taiwan's efforts to join the global fight against Ebola have gone relatively overlooked. In part, this is because Taiwan's participation is limited ó not by choice, but by continuing restrictions on its engagement with international organizations at Beijing's insistence.
More...




Life Science News

(Taiwan) GNTbm updates status of partnership with China's Chipscreen for development of anti-cancer drug Chidamide


(BiotechEast staff)

12 December, 2014
Taiwan's Gold Nanotech Biotech & Medicals Corporation (GNTbm) held a press event in Taipei on 10 December to announce updates in the regulatory status for Chidamide, a novel oral selective histone deacetylase (HDAC) inhibitor for cancer licensed from Chipscreen Biosciences Ltd. of Shenzhen, China. Additionally, GNTbm took the opportunity to give updates to its pipeline of drugs developed in-house using gold nanoparticles as the drug delivery mechanism.




Life Science News

(Taiwan) Swissray to enter Taiwan's capital market


(China Post)

27 November, 2014
Swissray Global (Swissray) held the pre-IPO investor conference yesterday in Taipei and revealed it expects its listing on the GreTai Security Market (GTSM) in late December.
More...




Life Science News

(Taiwan) TaiGen applies to NHIA to set price for new drug


(Taipei Times)

25 November, 2014
Drugmaker TaiGen Biotechnology Co. yesterday said it submitted an application to the National Health Insurance Administration (NHIA) on Tuesday last week to set the price of a new antibiotic, with the hope that the company would be able to sell the drug in Taiwan within six months after receiving the administrationís approval.
More...




Sponsors

Events







Taiwan Life Sciences Bulletin

Enter email address to receive free e-newsletter


Sample

Disclaimer and Privacy Policy